ARCHIVES

Biotherapeutics Reports LAK/IL-2 Toxicity Reduced With Constant Infusion Of IL-2

This article is from The Cancer Letter archive.

Vol. 13 No. 16 | April 17, 1987

Download PDF Visit The Full Archive

Related Articles

HCFA Chief Says Facts Will Not Matter, She Won’t Loosen DRGs For Clinical Trials Unless Congress Orders It

May 4, 1984

Nominations Sought For Paul Marks Prizes, Recognizing Discoverise By The Under-45 Set.

April 13, 2001

DePinho’s Letter to the AAUP

May 30, 2014

Pitt Criticizes NCI Stance On Repayment For Fraud Trials

September 9, 1994

In Brief: Issell To Retire As Hawaii Center Director; M.D. Anderson honors LeMaistre, Faculty

November 8, 1996

Men With PSA Of 7 Or Higher More Likely To Have Biopsy

February 25, 2005